Equilis Prequenza Suspension for injection for horses.
Indications for use
Active immunisation of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection.
Onset of immunity:
2 weeks after completion of the primary vaccination course.
Duration of immunity:
5 months after completion of the primary vaccination course.
12 months after the first revaccination.
Special warnings for each target species
Foals should not be vaccinated before the age of 6 months, especially when born to mares that were revaccinated in the last two months of gestation, because of possible interference by maternally derived antibodies.
Special precautions for use
Only healthy animals should be vaccinated.
Special precautions for use in animals
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
A diffuse hard or soft swelling (max. diameter 5 cm) may occur at the injection site, regressing within 2 days. In very rare cases a local reaction exceeding 5 cm and possibly persisting longer than 2 days may occur. Pain at the injection site can occur in rare cases, which may result in temporary functional discomfort (stiffness). In very rare cases, fever, sometimes accompanied by lethargy and inappetence, may occur for 1 day, and up to 3 days in exceptional circumstances.
Use during pregnancy, lactation or lay
Can be used during pregnancy and lactation.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Amounts to be administered and administration route
Primary vaccination course
Administer one dose (1ml), by strict intramuscular injection, according to the following schedule:
•Primary vaccination course: first injection from 6 months of age, second injection 4 weeks later.
The first revaccination (third dose) is given 5 months after the primary vaccination course. This revaccination results in immunity to equine influenza lasting at least 12 months.
The second revaccination is given 12 months after the first revaccination.
The alternate use, at 12 months interval, of a suitable vaccine against equine influenza, containing the strains A/equine-2/South Africa/4/03 and A/equine-2/Newmarket-2/93, is recommended to maintain immunity levels for the influenza component (see schedule).
Vaccination schedule table - Equilis Prequenza
In case of increased infection risk or insufficient colostrum intake, an additional initial injection can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 6 months of age and 4 weeks later).
Following the administration of a double dose of vaccine, no side-effects other than those described in section "Adverse Reactions" have been observed except for some depression at the day of vaccination.
To stimulate active immunity against Equine influenza
ATC-vet code: QI05AA01
Do not mix with any other veterinary medicinal product.
Shelf life of the veterinary medicinal product as packaged for sale: 2 years.
Special precautions for storage
Store at 2 °C - 8 °C, protected from light. Do not freeze.
Type I glass vial closed with a halogenobutyl rubber stopper and sealed with an aluminium cap.
Type I glass pre-filled syringe, containing a plunger with a halogenobutyl end and closed with a halogenobutyl stopper.
10 vials of 1 ml.
1, 5 or 10 pre-filled syringes with needles.
Not all pack sizes may be marketed.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.